Quajune Chance, | |
2316 N Rockwell Ave, Bethany, OK 73008-5852 | |
(405) 440-0342 | |
Not Available |
Full Name | Quajune Chance |
---|---|
Gender | Male |
Speciality | Pharmacist |
Location | 2316 N Rockwell Ave, Bethany, Oklahoma |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1043922081 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
183500000X | Pharmacist | I-10733 (Oklahoma) | Primary |
Mailing Address | Practice Location Address |
---|---|
Quajune Chance, 4317 Sw 22nd St Apt 1902, Oklahoma City, OK 73108-1942 Ph: (215) 789-0745 | Quajune Chance, 2316 N Rockwell Ave, Bethany, OK 73008-5852 Ph: (405) 440-0342 |
News Archive
Aileron Therapeutics and Roche announced today that they have entered into a collaboration to discover, develop and commercialise a new class of drugs called Stapled Peptide Therapeutics. As part of this agreement, Roche will work with Aileron to develop drug candidates against up to five undisclosed targets selected from Roche's key therapeutic areas, which include oncology, virology, inflammation, metabolism and CNS.
An IRS rule could mean some working-class families may not be able to afford employer-sponsored insurance nor qualify for federal subsidies under the health law, leaving a key part of America uninsured. Childless adults, however, are in line for significant health insurance coverage gains under the health law's Medicaid expansion.
A team of University of South Carolina researchers led by Mitzi Nagarkatti, Prakash Nagarkatti and Xiaoming Yang have discovered a novel pathway through which marijuana can suppress the body's immune functions. Their research has been published online in the Journal of Biological Chemistry.
According to a recent report published in Occupational and Environmental Medicine, scientists have found that women during her mid 30's exposed to petrol products and synthetic fibers could treble the risk of developing breast cancer after menopause. According to the report, "Occupational exposure to nylon and acrylic fibers as well as to polycyclic aromatic hydrocarbons has higher risk of developing postmenopausal breast cancer."
Biotechnology Industry Organization (BIO) President and CEO Jim Greenwood issued the following statement regarding the newly released U.S. Food and Drug Administration (FDA) guidance for the review and approval of biosimilars.
› Verified 8 days ago
Katelyn Lindsey Owen, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2316 N Rockwell Ave, Bethany, OK 73008 Phone: 405-440-0342 | |
Thanh Nha Duong, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 7101 Nw 23rd St, Bethany, OK 73008 Phone: 405-789-2596 | |
Velda Journey, D.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 6801 Nw 39th Expy, Bethany, OK 73008 Phone: 405-789-2453 | |
Jason Scott Girard, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2316 N Rockwell Ave, Bethany, OK 73008 Phone: 405-440-0342 | |
Tanya Billingsley, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2316 N Rockwell Ave, Bethany, OK 73008 Phone: 405-440-0342 | |
Mr. Scott E Terrell, DPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2316 N Rockwell Ave, Bethany, OK 73008 Phone: 405-440-0342 |